Candel Therapeutics Growth Metrics (2020-2025) | CADL

Growth Metrics Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
-4.68M-4.39M6.06M-1.40M2.69M2.35M-5.27M
EBITDA Margin (QoQ) (Quarter)
1.89M-4.01M0.30M7.87M-5.56M0.08M-0.04M0.25M
EBIT Margin Growth (1y) (Quarter)
-0.87M-1.70M-10.92M-1.40M-1.11M-0.27M10.29M
EBIT Margin (QoQ) (Quarter)
0.47M-0.21M-0.88M-10.31M10.00M0.08M-0.04M0.25M
EBT Margin Growth (1y) (Quarter)
-0.90M-1.72M-10.96M-1.45M-1.23M-0.33M10.38M
EBT Margin (QoQ) (Quarter)
0.45M-0.21M-0.88M-10.32M9.96M0.01M0.02M0.38M
Enterprise Value Growth (1y) (Quarter)
-135.76%-256.89%12.67%15.23%37.17%40.20%44.31%49.45%56.61%58.57%61.48%-189.88%-258.44%-368.31%-425.20%-16.64%
Enterprise Value Growth (3y) (Quarter)
-0.34%4.02%42.78%-7.50%0.77%-5.08%-4.06%-19.56%
Enterprise Value Growth (5y) (Quarter)
-27.85%
Enterprise Value (QoQ) (Quarter)
-263.48%6.50%-14.13%7.99%11.06%9.23%15.42%12.43%17.17%17.61%27.39%16.38%22.99%-519.97%10.22%-9.25%13.63%-37.68%
FCF Margin Growth (1y) (Quarter)
-1.94M-8.01M-0.32M-1.27M-0.50M7.41M
FCF Margin (QoQ) (Quarter)
-0.86M1.27M-1.21M-7.22M6.84M0.32M-0.44M0.69M
Interest Coverage Ratio Growth (1y) (Quarter)
26.08%22.60%-9.39%22.67%-1.63%-35.76%-36.15%-117.20%-213.30%-356.20%46.71%
Interest Coverage Ratio Growth (3y) (Quarter)
-33.02%-68.61%7.41%
Interest Coverage Ratio (QoQ) (Quarter)
14.96%18.09%-12.86%5.96%10.95%-15.75%20.21%-23.58%-18.95%-16.09%-27.28%-78.26%-73.21%86.44%
Net Margin Growth (1y) (Quarter)
-0.90M-1.72M-10.96M-1.45M-1.23M-0.33M10.38M
Net Margin (QoQ) (Quarter)
0.45M-0.21M-0.88M-10.32M9.96M0.01M0.02M0.38M
Operating Margin Growth (1y) (Quarter)
-0.87M-1.70M-10.92M-1.40M-1.11M-0.27M10.29M
Operating Margin (QoQ) (Quarter)
0.47M-0.21M-0.88M-10.31M10.00M0.08M-0.04M0.25M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.00-1.000.00M1.001.001.000.00M
Return on Assets Growth (3y) (Quarter)
-1.000.00M0.00M0.00M0.00M0.00M
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M1.000.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter)
-37.00-0.00M-0.00M-0.00M-0.00M-0.01M-0.01M-0.02M-0.03M-308.000.01M0.02M0.04M0.01M
Return on Capital Employed Growth (3y) (Quarter)
-0.04M-0.01M-789.00-539.00-448.00-223.00
Return on Capital Employed (QoQ) (Quarter)
0.00M-393.00-317.00-467.00-458.00-676.00-0.00M-0.00M-0.00M-0.00M-0.01M-0.02M0.03M0.01M-67.00-376.00-232.00
Return on Equity Growth (1y) (Quarter)
-1.00-1.002.000.00M0.00M0.00M-1.00-1.00-3.0019.004.001.004.00-19.00-3.001.00
Return on Equity Growth (3y) (Quarter)
-5.0018.005.00-1.000.00M0.00M0.00M0.00M
Return on Equity (QoQ) (Quarter)
0.00M-3.002.000.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-2.0022.00-15.00-4.001.000.00M0.00M0.00M
Return on Sales Growth (1y) (Quarter)
-90.00-172.00-0.00M-145.00-123.00-33.000.00M
Return on Sales (QoQ) (Quarter)
45.00-21.00-88.00-0.00M996.001.002.0038.00